EVALUATION METHOD FOR RISK OF METASTASIS OR RECURRENCE OF COLON CANCER

WIPO Patent Application WO/2015/115544

A1

Provided is a method for objectively and rapidly predicting the risk of metastasis or recurrence of colon cancer with high precision. This method includes a step for measuring expression levels in one or more types of expression products in DNA including transcription initiation regions for biological samples derived from cancerous tissue isolated from colon cancer patients, and evaluates the risk of metastasis or recurrence of colon cancer in those patients.

JP2021533826	Precisely modified concealed messenger RNA and other polynucleotides
WO1999051781	HEPATITIS C VIRUS NS5B COMPOSITIONS AND METHODS OF USE THEREOF
JP2009060891	CHIMERIC MOLECULE CONTAINING MODULE ABLE TO TARGET SPECIFIC CELL AND MODULE REGULATING APOPTOGENIC FUNCTION OF PERMEABILITY TRANSITION PORE COMPLEX (PTPC)

KOMIYAMA HIROMITSU (JP)
SAKAMOTO KAZUHIRO (JP)
OKUZAWA ATSUSHI (JP)
SHIOZAWA MANABU (JP)
AKAIKE MAKOTO (JP)
MIYAGI YOHEI (JP)
OHTSU TAKASHI (JP)
HAYASHIZAKI YOSHIHIDE (JP)
ITO MASAYOSHI (JP)
KAWAJI HIDEYA (JP)
OOMIYA HIROKO (JP)

PCT/JP2015/052521

August 06, 2015

January 29, 2015

Click for automatic bibliography generation  

JUNTENDO EDUCATIONAL FOUNDATION (JP)
KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION (JP)
RIKEN (JP)

C12N15/09; C12Q1/68; G01N33/53

JP2012525159A	2012-10-22
JP2013099253A	2013-05-23

TAKASHI OSHIMA ET AL.: "Search for gastroenterological cancer bio-markers using clinical samples", YOKOHAMA IGAKU, vol. 60, no. 1 / 2, 2009, pages 49 - 56
TAKASHI OSHIMA ET AL.: "Shokaki Gan no biomarker Kensaku to Kobetsuka Chiryo eno Kokoromi", JOURNAL OF JAPAN SURGICAL SOCIETY, vol. 113, 2012, pages 160
GIRALDEZ M.D. ET AL.: "Gene -expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.", INT.J.CANCER, vol. 132, no. 5, 2013, pages 1090 - 1097, XP055217454
ARTINYAN A. ET AL.: "Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression.", J.GASTROINTEST.SURG., vol. 9, no. 9, 2005, pages 1216 - 1221, XP005197222

THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Patent business corporation Alga patent firm (JP)

View/Download PDF      PDF Help

Previous Patent: METHOD FOR MANUFACTURING CRYSTAL

Next Patent: METHOD FOR EVALUATING OF METASTASIS OR RISK OF RECURRENCE OF BREAST CANCER